Sanofi-Aventis U.S. LLC

Complete recall history across all FDA and CPSC categories — 22 total recalls

Sanofi-Aventis U.S. LLC appears in recall records across 1 category. This page consolidates all FDA food, drug, and medical device enforcement actions, plus CPSC consumer product recalls associated with this company. Recall data is sourced from openFDA and CPSC public databases.

Drug Recalls (22)

FDA drug safety enforcement actions by Sanofi-Aventis U.S. LLC

Date Product Reason Class
Apr 11, 2023 Admelog, insulin lispro injection, 100 units/mL (U-100), 3mL multi-dose vial,... Lack of Assurance of Sterility: Malformed crimped collar seal Class II
Aug 10, 2020 Elitek (rasburicase) for injection, 7.5 mg vial, Rx Only Mfd. by Sanofi - Ave... Failed Stability Specifications: Out of Specification result for enzyme activ... Class II
Oct 22, 2019 Regular Strength Zantac 150 mg Distributed by: Chattem, Inc., a Sanofi Compan... CGMP Deviations: Presence of NDMA impurity detected in product. Class II
Oct 22, 2019 Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, ... CGMP Deviations: Presence of NDMA impurity detected in product. Class II
Oct 22, 2019 Regular Strength Zantac 150 mg, Distributed by: Chattem, Inc., a Sanofi Compa... CGMP Deviations: Presence of NDMA impurity detected in product. Class II
Oct 22, 2019 Regular Strength Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Compan... CGMP Deviations: Presence of NDMA impurity detected in product. Class II
Oct 22, 2019 Cool Mint Maximum Strength Zantac 150 mg, Distributed by: Chattem, Inc., a Sa... CGMP Deviations: Presence of NDMA impurity detected in product. Class II
Oct 22, 2019 Maximum Strength Zantac 150 mg, Distributed by: Chattem, Inc., a Sanofi Compa... CGMP Deviations: Presence of NDMA impurity detected in product. Class II
Oct 22, 2019 Maximum Strength Zantac 150 mg Distributed by: Chattem, Inc., a Sanofi Compan... CGMP Deviations: Presence of NDMA impurity detected in product. Class II
Oct 22, 2019 Regular Strength Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Compan... CGMP Deviations: Presence of NDMA impurity detected in product. Class II
Oct 22, 2019 Zantac 150 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219,... CGMP Deviations: Presence of NDMA impurity detected in product. Class II
Oct 22, 2019 Regular Strength Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Compan... CGMP Deviations: Presence of NDMA impurity detected in product. Class II
Oct 22, 2019 Regular Strength Zantac 75 mg, Distributed by: Chattem, Inc., a Sanofi Compan... CGMP Deviations: Presence of NDMA impurity detected in product. Class II
Oct 22, 2019 Cool Mint Tablets Maximum Strength Zantac 150 mg Sanofi Distributed by: Chatt... CGMP Deviations: Presence of NDMA impurity detected in product. Class II
Jul 5, 2018 Admelog Solostar (insulin lispro injection), 100 units/ mL (U-100) injection,... Temperature Abuse: Product samples of Admelog may not have been shipped at pr... Class II
Apr 27, 2018 Docetaxel injection concentrate, 20 mg/mL, 1 mL vial, Rx only, Winthrop U.S. ... Superpotent drug: over-concentrated vials of Docetaxel injection concentrate ... Class II
Dec 5, 2017 Enoxaparin Sodium, Injection 120 mg/0.8 mL, pre-filled, packaged in 10-count ... Labeling: Label Error on Declared Strength. A single syringe labeled as 150 m... Class III
Oct 13, 2017 Clofarabine injection, 20 mg/20 mL, 20 mL Single-Use Vial, Rx only, Mfd by: T... Labeling: Incorrect or Missing Package Insert: authorized generic product was... Class III
Jun 12, 2017 Gaviscon (Alumina & Magnesium Trisilicate) Regular Strength Original Flavor C... Superpotent Drug: high out-of-specification result for magnesium. Class III
Sep 1, 2016 Mozobil (plerixafor injection) 24mg/1.2mL (20mg/mL), For Single Use Only, Rx ... Labeling: Incorrect or Missing Package Insert Class III
Oct 28, 2015 Auvi-Q (epinephrine injection, USP) Auto-Injector, 0.15 mg (a) 2 prefilled au... Defective Delivery System; potential to have inaccurate dosage delivery Class I
Oct 28, 2015 Auvi-Q (epinephrine injection, USP) Auto-Injector, 0.3 mg (a) 2 prefilled aut... Defective Delivery System; potential to have inaccurate dosage delivery Class I

Frequently Asked Questions

A high number of recalls does not necessarily indicate that a company is unsafe. Large manufacturers that produce thousands of products across multiple categories will statistically appear in recall databases more frequently. What matters more is the severity of each recall (Class I being the most serious), the speed of response, and whether the company proactively identified and addressed the issue. Companies with robust safety programs often catch problems earlier.

Food, drug, and medical device recall data comes from the FDA's openFDA enforcement database, which contains all FDA enforcement reports. Consumer product recall data comes from the U.S. Consumer Product Safety Commission (CPSC). Both sources are public government databases that are updated regularly. RecallCheck aggregates these sources to provide a unified view of a company's recall history.

The FDA classifies recalls into three categories. Class I is the most serious — there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. Class II means the product may cause temporary or medically reversible health problems, or the probability of serious consequences is remote. Class III is the least serious — the product is unlikely to cause adverse health consequences. CPSC product recalls do not use this classification system.

Yes. You can search for any company using the firm/manufacturer pages for each category: Food Firms, Drug Firms, Device Firms, or Product Manufacturers. You can also use the search functionality on any browse page to find recalls by company name.

Explore More Recalls

Search recalls by category, state, reason, or firm across all our databases.